Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,D-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

European Journal of Nuclear Medicine

Volumn 24, Issue 4, 1997, Pages 368-371

  De Jong, Marion ^a   Bakker, Willem H ^a   Krenning, Eric P ^a   Breeman, Wout A P ^a   Van Der Pluijm, Marcel E ^a   Bernard, Bert F ^a   Visser, Theo J ^a   Jermann, Eduard ^b   Béhé, Martin ^b   Powell, Pia ^b   Mäcke, Helmut R ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Biodistribution; Indium 111; Receptor binding; Yttrium 90; DOTA0,D Phe1,Tyr3 octreotide

Indexed keywords

INDIUM 111; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; YTTRIUM 90;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG MIXTURE; HYPOPHYSIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; MICROSOME; NEUROENDOCRINE TUMOR; NONHUMAN; PANCREAS; RADIOTHERAPY; RAT; RECEPTOR BINDING; TUMOR;

EID: 0042929352     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00881807     Document Type: Article

References (7)

1. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
2. Krenning EP, Kooij PPM, Pauwels S, Breeman WAP, Postema PTE, De Herder WW, Valkema R, Kwekkeboom DJ. Somatostatin receptor scintigraphy and radionuclide therapy. Digestion 1996; 57: 57-61.
3. Stolz B, Smith-Jones PM, Albert R, Tolesvai L, Briner U, Ruser B, Mäcke H, Weckbecker G, Bruns C. Somatostatin analogues for somatostatin-receptor-mediated radiotherapy of cancer. Digestion 1996; 57: 17-21.
4. Rowlinson G, Snook D, Stewart S, Epenetos AA. Intravenous EDTA to reduce bone uptake of Y-90 following Y-90 labeled antibody administration. Br J Cancer 1989; 59: 322.
5. Jowsey J, Rowland RE, Marshall JH. The deposition of the rare earths in bone. Radiat Res 1958; 8: 490-501.
6. 1]octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumours: synthesis, radiolabelling and in vitro validation. Life Sci 1991; 49: 1583-1591.
7. Bruns C, Dietl MM, Palacios JM, Pless J. Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem J 1990; 265: 39-44.